NDT Advance Access originally published online on May 30, 2006
Nephrology Dialysis Transplantation 2006 21(10):2881-2892; doi:10.1093/ndt/gfl272
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The association of lipid levels with mortality in patients on chronic peritoneal dialysis
1Division of Nephrology and Hypertension, University of Utah School of Medicine and 2Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, USA
Correspondence and offprint requests to: Arsalan N. Habib, MD, Dialysis Program, University of Utah School of Medicine, 30 North Medical Drive, Rm. 4R312, Salt Lake City, UT 84132, USA. Email: Arsalan.Habib{at}hsc.utah.edu
Background. The role of traditional risk factors, including plasma lipids, in the pathogenesis of cardiovascular (CV) disease in chronic dialysis patients is unclear. Previous studies have suggested that lower serum total cholesterol (TC) is associated with higher mortality in patients on chronic haemodialysis (HD). Whether this relationship is specific to the HD population or is common to the uraemic state is unclear. The present study evaluated the association of serum TC and triglycerides with clinical outcomes in chronic peritoneal dialysis (PD) patients.
Methods. Data of 1053 PD patients from the United States Renal Data System (USRDS) prospective Dialysis Morbidity and Mortality Study Wave 2 were examined. Cox regression was used to evaluate the relationship between lipid levels and mortality.
Results. Patients with TC levels 
125 mg/dl (3.24 mmol/l) had a statistically significant increased risk of an all-cause mortality, including those taking or not taking lipid-modifying medications, compared with the reference of 176–225 mg/dl (4.54–5.83 mmol/l). In stratified analysis, this association was demonstrated in patients with serum albumin >3.0 g/dl (30 g/l), but not with albumin 3.0 g/dl.
Compared with patients with triglyceride levels of 201–300 mg/dl (2.27–3.39 mmol/l), a statistically significant reduction of all-cause, but not CV, mortality was observed in patients with triglyceride levels of 101–200 mg/dl (1.14–2.26 mmol/l), as well as in the subgroup with serum albumin levels <3.0 g/dl (30 g/l) and triglycerides of 100 mg/dl (1.13 mmol/l) and 101–200 mg/dl (1.14–2.26 mmol/l).
Conclusions. While confounding factors and causal pathways have not been clearly identified, aggressive lowering of plasma cholesterol in PD patients is not supported by this study, however, treatment of hypertriglyceridaemia may be warranted with triglyceride levels >200 mg/dl (2.26 mmol/l).
Keywords: cholesterol; lipids; mortality; peritoneal dialysis; triglycerides
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Svensson, E. B. Schmidt, K. A. Jorgensen, and J. H. Christensen The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2918 - 2924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Van Biesen, F. Verbeke, and R. Vanholder Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis Nephrol. Dial. Transplant., January 1, 2007; 22(1): 53 - 58. [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Kovesdy, J. E. Anderson, and K. Kalantar-Zadeh Inverse Association between Lipid Levels and Mortality in Men with Chronic Kidney Disease Who Are Not Yet on Dialysis: Effects of Case Mix and the Malnutrition-Inflammation-Cachexia Syndrome J. Am. Soc. Nephrol., January 1, 2007; 18(1): 304 - 311. [Abstract] [Full Text] [PDF]
|
|